Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 10/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.45 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.45 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.45 |
| ▸ | PYGM | P11217 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6015184 | 1.00 | CDA (0.66) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| SCHEMBL30241991 | 1.00 | CDA (0.66) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| SCHEMBL18512842 | 1.00 | CDA (0.66) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| SCHEMBL18503564 | 1.00 | CDA (0.66) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| SCHEMBL11757296 | 1.00 | CDA (0.66) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| SCHEMBL18512836 | 1.00 | CDA (0.66) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| SCHEMBL40762 | 1.00 | CDA (0.66) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| Phosphoric Acid SCHEMBL3517608 | 0.94 | CDA (0.60) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| SCHEMBL8772894 | 0.93 | CDA (0.59) | CDAMAPTSLC28A1SLC28A2SLC29A1 | |
| SCHEMBL20788751 | 0.87 | CDA (0.60) | CDAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3484 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109727-A1 | RNA CONSTRUCTS AND USES THEREOF | BioNTech SE (DE) | 2026-04-23 | — | — | US | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| EP-4696703-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2026-02-18 | — | — | EP | claimed |
| US-20250340868-A1 | POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF | STEMCELL TECHNOLOGIES CANADA INC (CA) | 2025-11-06 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4631970-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2025-10-15 | — | — | EP | claimed |
| US-20250295744-A1 | TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION AND PD-1 AXIS BINDING ANTAGONISTS | BioNTech SE (DE) | 2025-09-25 | — | — | US | claimed |
| US-20250277223-A1 | METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES | IMCYSE SA (BE) | 2025-09-04 | — | — | US | claimed |
| US-20250263678-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | REJUVENATION TECHNOLOGIES, INC. (US) | 2025-08-21 | — | — | US | claimed |
| EP-4598935-A2 | RNA CONSTRUCTS AND USES THEREOF | BioNTech SE (DE) | 2025-08-13 | — | — | EP | claimed |
| WO-2021197589-A1 | TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION | BioNTech SE (DE) | 2021-10-07 | — | — | WO | claimed |
| US-20200261379-A1 | BIOMARKERS FOR EFFICACY OF PROPHYLACTIC TREATMENTS AGAINST STRESS-INDUCED AFFECTIVE DISORDERS | BPG BIO, INC. | 2020-08-20 | — | — | US | claimed |
| US-20200061166-A1 | RNA FOR TREATMENT OF AUTOIMMUNE DISEASES | BioNTech SE (DE) | 2020-02-27 | — | — | US | claimed |
| EP-3609529-A1 | RNA FOR TREATMENT OF AUTOIMMUNE DISEASES | BioNTech RNA Pharmaceuticals GmbH (DE) | 2020-02-19 | — | — | EP | claimed |
| CN-110719787-A | RNA for treating autoimmune diseases | 生物技术RNA制药有限公司 | 2020-01-21 | — | — | CN | claimed |
| US-20190310269-A1 | SYSTEMS AND METHODS FOR MEASURING OBESITY USING METABOLOME ANALYSIS | HUMAN LONGEVITY, INC. | 2019-10-10 | — | — | US | claimed |
| WO-2018189193-A1 | RNA FOR TREATMENT OF AUTOIMMUNE DISEASES | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2018-10-18 | — | — | WO | claimed |
| WO-2018188730-A1 | RNA FOR TREATMENT OF AUTOIMMUNE DISEASES | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2018-10-18 | — | — | WO | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |